2019: Another triumphant year for the HARMONY Alliance!

2019 has been an exciting year for the HARMONY Alliance: 45 000 data records of people with blood cancer have been identified and researchers have made headway in several critical research projects.

#BigDataforBloodCancer

The HARMONY Executive Committee, Steering Committee, Work Package Leads, Research Projects Leads, Project Management Team and Communication Team extends its gratitude to all those who have contributed to the success of HARMONY over the past year.

It is with continued support from our Partners and Associated Members that we have been able to make progress in our goals to enable better and faster treatment for patients with blood cancer.

Since our launch in January 2017, HARMONY has continued to evolve and gain momentum. By the end of 2019, we will have identified 45 000 medical records of patients with blood cancer to be included in the HARMONY Big Data Platform, making it one of the largest databases of its kind. HARMONY researchers have been using the Big Data Platform to generate important evidence that is moving us closer to our goal of improving and accelerating treatment for patients with blood cancer.

Achievements by end of 2019

45 000 Data sets identified
7 Blood cancer Research projects up and running
5 Full manuscripts in scientific journals to date
11 Scientific research posters developed to date
3 Scientific research awards received
2 Newly approved research projects
12 Conferences attended
4 Dedicated sessions organized
Successful collaborations between Partners, Patient Cluster and Association Members
90 organization involved, leading up to 300 HARMONY Ambassadors in our community

What’s in store for 2020?

There are a number of exciting new research projects, scientific communications and meetings lined up for next year.

HARMONY researchers will begin addressing a new set of research questions that were identified by our Partners and patient organizations at the 4th General Assembly in September 2019. Collaborative efforts such as these have contributed to the growth of HARMONY and we will be holding similar events in 2020, which we hope will be equally successful.
We will continue to communicate and publish results from all HARMONY Research Projects to increase awareness of the meaningful work being conducted in blood cancer. In parallel, we will remain active in acquiring new patient data to meet our goal of capturing 100 000 patient records in the HARMONY Big Data Platform. These activities remain at the core of HARMONY’s success and are bringing us closer to improving treatments for people with blood cancer.
In the near future, we hope to initiate research in more blood cancers to enable even more patients to benefit from HARMONY. We are also exploring new ways to expand on the types of data that can be captured in the Big Data Platform and further promote data sharing.
Finally, we have several scientific communications planned to further increase awareness of HARMONY among scientists and the general public, as well as to support our Partners and Associated Members. Our infographic explaining the Big Data Platform is an example of the type of material we are developing – look out for more over the next few months!

New to HARMONY? Here are three videos to get you up to speed

Why should you become a part of HARMONY?

If your organization has data from patients with Hematologic Malignancies to share, please contact us and learn how to become a HARMONY Associated Member – there is a lot to gain! You will:

have the opportunity to submit research proposals
work with dedicated research groups on key projects and learn from experts in Hematologic Malignancies
contribute to credible work published under the umbrella of HARMONY
have access to a greater evidence-base with which to conduct research
ultimately improve outcomes for patients.

About HARMONY

Established in January 2017, HARMONY is a public–private European Network of Excellence for Big Data in hematology. Our mission is to unlock and spread valuable knowledge on hematologic malignancies (blood cancers) among a large number of stakeholders, with the goal to harness and mine Big Data to speed up the development of improved treatments for patients and more effective treatment strategies. HARMONY currently has 53 Partners and 37 Associated Members from 22 countries.

HARMONY is funded through the Innovative Medicines Initiative (IMI), Europe's largest public–private initiative which aims to speed up the development of better and safer medicines for patients. HARMONY has received funding from IMI 2 Joint Undertaking and is listed under grant agreement No. 116026. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. Read more

Receive the latest news. Click here to subscribe!